Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-06

Clinical Trial Update: Characteristics of Treatment Responders to Galantamine [NA]

View source ↗

Summary

This completed clinical trial update describes the characteristics of patients who showed a response to galantamine treatment in dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Dementia | NA | Status: COMPLETED